• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将检测偏差纳入 SARS-CoV-2 流行动力学估计并加以解决。

Incorporating and addressing testing bias within estimates of epidemic dynamics for SARS-CoV-2.

机构信息

Department of Biomedical Engineering, University of Connecticut Health, Farmington, CT, USA.

Center for Cancer Systems Biology @ Yale, West Haven, CT, USA.

出版信息

BMC Med Res Methodol. 2021 Jan 7;21(1):11. doi: 10.1186/s12874-020-01196-4.

DOI:10.1186/s12874-020-01196-4
PMID:33413154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7789897/
Abstract

BACKGROUND

The disease burden of SARS-CoV-2 as measured by tests from various localities, and at different time points present varying estimates of infection and fatality rates. Models based on these acquired data may suffer from systematic errors and large estimation variances due to the biases associated with testing. An unbiased randomized testing to estimate the true fatality rate is still missing.

METHODS

Here, we characterize the effect of incidental sampling bias in the estimation of epidemic dynamics. Towards this, we explicitly modeled for sampling bias in an augmented compartment model to predict epidemic dynamics. We further calculate the bias from differences in disease prediction from biased, and randomized sampling, proposing a strategy to obtain unbiased estimates.

RESULTS

Our simulations demonstrate that sampling biases in favor of patients with higher disease manifestation could significantly affect direct estimates of infection and fatality rates calculated from the numbers of confirmed cases and deaths, and serological testing can partially mitigate these biased estimates.

CONCLUSIONS

The augmented compartmental model allows the explicit modeling of different testing policies and their effects on disease estimates. Our calculations for the dependence of expected confidence on a randomized sample sizes, show that relatively small sample sizes can provide statistically significant estimates for SARS-CoV-2 related death rates.

摘要

背景

由不同地区和不同时间点的各种检测方法衡量的 SARS-CoV-2 疾病负担,对感染率和死亡率的估计各不相同。基于这些获得的数据的模型可能会由于与检测相关的偏差而存在系统误差和较大的估计方差。仍然缺乏一种无偏的随机检测方法来估计真实的死亡率。

方法

在这里,我们描述了在估计传染病动力学中偶然抽样偏差的影响。为此,我们在增强的隔间模型中明确建模了抽样偏差,以预测传染病动力学。我们进一步计算了来自偏差和随机抽样的疾病预测差异的偏差,并提出了一种获得无偏估计的策略。

结果

我们的模拟表明,偏向表现出更高疾病症状的患者的抽样偏差可能会严重影响从确诊病例和死亡人数计算得出的感染率和死亡率的直接估计值,血清学检测可以部分减轻这些有偏差的估计值。

结论

增强的隔室模型允许对不同的检测策略及其对疾病估计的影响进行明确建模。我们对随机样本量的期望置信度的依赖性的计算表明,相对较小的样本量可以为 SARS-CoV-2 相关死亡率提供具有统计学意义的估计值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/7792214/6aa0f22631f6/12874_2020_1196_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/7792214/9c534f285f98/12874_2020_1196_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/7792214/13587741d73e/12874_2020_1196_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/7792214/b7489513c0c6/12874_2020_1196_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/7792214/6aa0f22631f6/12874_2020_1196_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/7792214/9c534f285f98/12874_2020_1196_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/7792214/13587741d73e/12874_2020_1196_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/7792214/b7489513c0c6/12874_2020_1196_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdd/7792214/6aa0f22631f6/12874_2020_1196_Fig4_HTML.jpg

相似文献

1
Incorporating and addressing testing bias within estimates of epidemic dynamics for SARS-CoV-2.将检测偏差纳入 SARS-CoV-2 流行动力学估计并加以解决。
BMC Med Res Methodol. 2021 Jan 7;21(1):11. doi: 10.1186/s12874-020-01196-4.
2
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
3
Thoracic imaging tests for the diagnosis of COVID-19.用于诊断新型冠状病毒肺炎的胸部影像学检查
Cochrane Database Syst Rev. 2020 Sep 30;9:CD013639. doi: 10.1002/14651858.CD013639.pub2.
4
SARS-CoV-2 infection dynamics in Denmark, February through October 2020: Nature of the past epidemic and how it may develop in the future.2020 年 2 月至 10 月期间丹麦的 SARS-CoV-2 感染动态:过去疫情的性质及其未来可能的发展。
PLoS One. 2021 Apr 9;16(4):e0249733. doi: 10.1371/journal.pone.0249733. eCollection 2021.
5
Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission.广泛快速检测以降低 SARS-CoV-2 传播的临床和经济影响。
Ann Intern Med. 2021 Jun;174(6):803-810. doi: 10.7326/M21-0510. Epub 2021 Mar 9.
6
Analyzing inherent biases in SARS-CoV-2 PCR and serological epidemiologic metrics.分析 SARS-CoV-2 PCR 和血清流行病学指标中的固有偏倚。
BMC Infect Dis. 2022 May 13;22(1):458. doi: 10.1186/s12879-022-07425-z.
7
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.比较 SARS-CoV-2 与 SARS-CoV 和流感大流行。
Lancet Infect Dis. 2020 Sep;20(9):e238-e244. doi: 10.1016/S1473-3099(20)30484-9. Epub 2020 Jul 3.
8
Epidemiology and clinical features of emergency department patients with suspected COVID-19: Insights from Australia's 'second wave' (COVED-4).澳大利亚“第二波”疫情中急诊科疑似 COVID-19 患者的流行病学和临床特征(COVED-4)。
Emerg Med Australas. 2021 Apr;33(2):331-342. doi: 10.1111/1742-6723.13706. Epub 2021 Jan 6.
9
Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.封锁对欧洲和北美 7 个国家的新冠病毒病死率和病毒突变传播的影响。
J Transl Med. 2020 Sep 2;18(1):338. doi: 10.1186/s12967-020-02501-x.
10
Derivation and Internal Validation of a Model to Predict the Probability of Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Community People.社区人群中严重急性呼吸综合征冠状病毒 2 感染概率预测模型的推导和内部验证。
J Gen Intern Med. 2021 Jan;36(1):162-169. doi: 10.1007/s11606-020-06307-x. Epub 2020 Oct 26.

引用本文的文献

1
Diagnostic performance of allele-specific RT-qPCR and genomic sequencing in wastewater-based surveillance of SARS-CoV-2.等位基因特异性逆转录定量聚合酶链反应和基因组测序在基于废水的严重急性呼吸综合征冠状病毒2监测中的诊断性能
Eco Environ Health. 2025 Jan 21;4(1):100135. doi: 10.1016/j.eehl.2025.100135. eCollection 2025 Mar.
2
Nowcasting methods to improve the performance of respiratory sentinel surveillance: lessons from the COVID-19 pandemic.实时预测方法提高呼吸道传染病哨点监测的性能:从 COVID-19 大流行中获得的经验教训。
Sci Rep. 2024 May 31;14(1):12582. doi: 10.1038/s41598-024-62965-5.
3
Developing scientific literacy with a cyclic independent study assisted CURE detecting SARS-CoV-2 in wastewater.

本文引用的文献

1
Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures.封锁和放宽措施后 SARS-CoV-2 检测的流行病学和精准度。
J Med Virol. 2021 Apr;93(4):2374-2384. doi: 10.1002/jmv.26731. Epub 2020 Dec 29.
2
Collider bias undermines our understanding of COVID-19 disease risk and severity.撞击器偏差破坏了我们对 COVID-19 疾病风险和严重程度的理解。
Nat Commun. 2020 Nov 12;11(1):5749. doi: 10.1038/s41467-020-19478-2.
3
Confidence in the dynamic spread of epidemics under biased sampling conditions.在有偏抽样条件下对流行病动态传播的置信度。
通过循环自主学习辅助的CURE(一种在废水中检测新冠病毒的方法)培养科学素养。
J Microbiol Biol Educ. 2023 Oct 25;24(3). doi: 10.1128/jmbe.00147-23. eCollection 2023 Dec.
4
Wastewater surveillance in the COVID-19 post-emergency pandemic period: A promising approach to monitor and predict SARS-CoV-2 surges and evolution.新冠疫情后大流行时期的废水监测:一种监测和预测新冠病毒激增及演变的有前景的方法。
Heliyon. 2023 Nov 17;9(11):e22356. doi: 10.1016/j.heliyon.2023.e22356. eCollection 2023 Nov.
5
Rise and fall of SARS-CoV-2 variants in Rotterdam: Comparison of wastewater and clinical surveillance.SARS-CoV-2 变异株在鹿特丹的兴衰:废水和临床监测的比较。
Sci Total Environ. 2023 May 15;873:162209. doi: 10.1016/j.scitotenv.2023.162209. Epub 2023 Feb 14.
6
Exposure to infection when accessing groceries reveals racial and socioeconomic inequities in navigating the pandemic.在购买食品杂货时接触感染源,揭示了在应对大流行时,在获取资源方面存在着种族和社会经济方面的不平等。
Sci Rep. 2023 Feb 11;13(1):2484. doi: 10.1038/s41598-023-28194-y.
7
Challenges and Opportunities for Global Genomic Surveillance Strategies in the COVID-19 Era.新冠疫情时代全球基因组监测策略的挑战与机遇。
Viruses. 2022 Nov 16;14(11):2532. doi: 10.3390/v14112532.
8
Results from Canton Grisons of Switzerland suggest repetitive testing reduces SARS-CoV-2 incidence (February-March 2021).瑞士格劳宾登州的结果表明,重复检测可降低 SARS-CoV-2 的发病率(2021 年 2 月至 3 月)。
Sci Rep. 2022 Nov 14;12(1):19538. doi: 10.1038/s41598-022-23986-0.
PeerJ. 2020 Aug 14;8:e9758. doi: 10.7717/peerj.9758. eCollection 2020.
4
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.SARS-CoV-2 反应性 T 细胞在健康供体和 COVID-19 患者中的研究。
Nature. 2020 Nov;587(7833):270-274. doi: 10.1038/s41586-020-2598-9. Epub 2020 Jul 29.
5
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.2020年3月23日至5月12日美国10个地点针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体的血清流行率
JAMA Intern Med. 2020 Jul 21. doi: 10.1001/jamainternmed.2020.4130.
6
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.深度免疫剖析 COVID-19 患者,揭示具有治疗意义的不同免疫类型。
Science. 2020 Sep 4;369(6508). doi: 10.1126/science.abc8511. Epub 2020 Jul 15.
7
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.COVID-19 疾病患者和未接触者体内针对 SARS-CoV-2 冠状病毒的 T 细胞反应的靶标。
Cell. 2020 Jun 25;181(7):1489-1501.e15. doi: 10.1016/j.cell.2020.05.015. Epub 2020 May 20.
8
An Efficient COVID-19 Prediction Model Validated with the Cases of China, Italy and Spain: Total or Partial Lockdowns?一种在中国、意大利和西班牙的病例中得到验证的高效新冠病毒预测模型:全面封锁还是部分封锁?
J Clin Med. 2020 May 20;9(5):1547. doi: 10.3390/jcm9051547.
9
Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.2020 年 4 月 10 日至 11 日,加利福尼亚州洛杉矶县成年人中 SARS-CoV-2 特异性抗体的血清流行率。
JAMA. 2020 Jun 16;323(23):2425-2427. doi: 10.1001/jama.2020.8279.
10
Metagenomic Analysis Reveals Clinical SARS-CoV-2 Infection and Bacterial or Viral Superinfection and Colonization.宏基因组分析揭示了临床 SARS-CoV-2 感染以及细菌或病毒的合并感染和定植。
Clin Chem. 2020 Jul 1;66(7):966-972. doi: 10.1093/clinchem/hvaa106.